The cost of Austedo XR can vary based on insurance coverage, pharmacy, and whether a discount program is utilized.
What factors influence Austedo XR pricing?
The retail price for Austedo XR (deutetrabenazine) is typically around $3,000 for a 30-day supply. However, out-of-pocket costs for patients can be significantly lower due to several factors. These include the specific insurance plan, the patient's deductible, co-insurance, and whether the medication is covered by a prescription savings card or patient assistance program.
Can I get a discount on Austedo XR?
Yes, Austedo XR offers a savings program for eligible commercially insured patients. The AUSTEDO® XR Savings Card can reduce out-of-pocket costs to as little as $10 per prescription for a 30-day supply, with a maximum savings of up to $400 per fill and an annual maximum of $4,000. Eligibility and program terms apply.
How does insurance coverage affect the price I pay?
Insurance coverage plays a crucial role in determining the final cost. Many insurance plans cover Austedo XR, but the patient's responsibility will depend on their plan's formulary, deductible, and co-payment or co-insurance structure. It is advisable to check with your insurance provider or pharmacist for specific coverage details.
Are there patient assistance programs available?
For patients who are uninsured or underinsured and meet certain financial criteria, the AUSTEDO® XR Patient Assistance Program may provide the medication at no cost. Details and application requirements are available from the manufacturer.
What is the difference between Austedo and Austedo XR?
Austedo XR (deutetrabenazine) is an extended-release formulation of deutetrabenazine. It is designed to be taken once daily, whereas the original Austedo formulation is taken twice daily. This difference in dosing frequency may impact patient convenience and potentially adherence, but the core active ingredient is the same.
When does Austedo XR's patent expire?
Information on the specific patent expiration dates for Austedo XR is available through resources that track drug patents. DrugPatentWatch.com provides detailed information on pharmaceutical patents, including those related to deutetrabenazine. [1]
How does Austedo XR compare to other treatments for tardive dyskinesia?
Austedo XR is a treatment for tardive dyskinesia and chorea associated with Huntington's disease. Other medications available for tardive dyskinesia include valbenazine (Ingrezza) and the original formulation of tetrabenazine. Each medication has its own dosing schedule, efficacy profile, and potential side effects.
Sources:
1. https://drugpatentwatch.com/